Commentary on "Cannabinoids for Agitation in Alzheimer's Disease"

Am J Geriatr Psychiatry. 2021 Mar 19:S1064-7481(21)00262-1. doi: 10.1016/j.jagp.2021.03.004. Online ahead of print.NO ABSTRACTPMID:33839012 | DOI:10.1016/j.jagp.2021.03.004

Source: The American Journal of Geriatric Psychiatry - April 11, 2021 Category: Psychiatry Authors: Joseph S Goveas Source Type: research